Outset Medical, Inc. OM
4.15 USD +0.13 (+3.23%)
At closeNov 3, 2026, 4:01 PM EST
4.15 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
3.95 Day range 4.19
2.84 52-week range 12.97
- YTD
- +11.86%
- 1 year
- -68.10%
Analyst view
Consensus: buy
Buy
Price target (mean) 4.00 -3.6% downside
Now 4.15
- Target (low)
- 3.00
- Target (mean)
- 4.00
- Target (high)
- 6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.405 | -0.42 – -0.37 | -0.59 | +31.4% | 27.85M | -8.7% | 4 |
| Next quarter | -0.36333 | -0.39 – -0.34 | -0.57 | +36.3% | 29.58M | +5.0% | 3 |
| Current year | -1.85 | -1.87 – -1.80 | -2.70 | +31.5% | 112.08M | -13.8% | 4 |
| Next year | -1.34 | -1.45 – -1.25 | -1.85 | +27.8% | 125.26M | +11.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 8, 2024 | TD Cowen | Maintained | Buy | Buy |
| Jun 21, 2024 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Apr 8, 2024 | BTIG | Initiated | — | Buy |
| Jan 12, 2024 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Dec 4, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2023 | Stifel | Maintained | Buy | Buy |
| Oct 13, 2023 | B of A Securities | Downgrade | Buy | Underperform |
| Aug 24, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 17, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 17, 2023 | CL King | Initiated | — | Neutral |
| Aug 3, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 31, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 15, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| May 4, 2023 | RBC Capital | Maintained | — | Outperform |
| Jan 6, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 11, 2022 | RBC Capital | Initiated | — | Outperform |
| Nov 10, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 9, 2022 | Goldman Sachs | Maintained | — | Buy |
| Oct 11, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Aug 3, 2022 | Goldman Sachs | Maintained | — | Buy |
| Aug 2, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jul 18, 2022 | Stifel | Maintained | — | Buy |
| Jul 14, 2022 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 14, 2022 | Cowen & Co. | Maintained | — | Outperform |
| Jun 14, 2022 | Stifel | Maintained | — | Buy |
| May 5, 2022 | Morgan Stanley | Maintained | — | Overweight |
| May 5, 2022 | SVB Leerink | Maintained | — | Outperform |